Eaton Vance Management’s Insmed INSM Stock Holding History

Eaton Vance Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,046	Closed	-$36K	–	2921
2021 Q1	$36K	Buy	+1,046	New	+$40K	﹤0.01%	1879

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Eaton Vance Management's INSM Position: Q2 2021 in Review

Eaton Vance Management sold out of Insmed (INSM) in Q2 2021, closing a stake of 1,046 shares — an estimated $36K sold.

Eaton Vance Management first reported a position in INSM in Q1 2021 and held it in 1 quarter. The position peaked at $36K in Q1 2021. 203 funds tracked by Wall St. Rank hold INSM as of Q2 2021.

Eaton Vance Management reported no remaining Insmed position as of Q2 2021 after selling out during the quarter.
Eaton Vance Management sold 1,046 Insmed shares in Q2 2021, an estimated $36K.
Eaton Vance Management first reported a position in Insmed in Q1 2021 and held it in 1 quarter.
Eaton Vance Management's Insmed position peaked at $36K in Q1 2021.
203 funds tracked by Wall St. Rank held Insmed as of Q2 2021.

Based on Eaton Vance Management's 13F filing for Q2 2021, filed 16 Aug 2021.